Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2018 07:30 ET | Source: Fundamental Markets

Report: Exploring Fundamental Drivers Behind Berry Petroleum, Quotient, Virco Manufacturing, Corvus Pharmaceuticals, Marine Products, and Hamilton Beach Brands Holding — New Horizons, Emerging Trends, and Upcoming Developments

NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders,...
November 13, 2018 07:30 ET | Source: Innovation Pharmaceuticals, Inc.

Innovation Pharmaceuticals Presenting Brilacidin for Inflammatory Bowel Disease at “IBD Innovate 2018” Conference Hosted by the Crohn’s & Colitis Foundation

BEVERLY, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to announce that the Company is...
November 13, 2018 07:30 ET | Source: Calm

Calm Increases Offline Presence with Retail Rollout, Investment in XpresSpa Group Inc.

Sleep, meditation and relaxation app invests up to $3 million to bring mindfulness offerings to 52 XpresSpa brick-and-mortar locations nationwide SAN FRANCISCO, Nov. 13, 2018 (GLOBE NEWSWIRE) --...
November 13, 2018 07:30 ET | Source: TG Therapeutics, Inc.

TG Therapeutics Announces Phase I Study of Novel BTK inhibitor, TG-1701, in Patients with Relapsed or Refractory B-cell Malignancies is Open for Enrollment

First dose cohort fully enrolled First patient enrolled with relapsed/refractory Mantle Cell Lymphoma achieved Partial Response (PR) to lowest dose being tested NEW YORK, Nov. 13, 2018 (GLOBE...
November 13, 2018 07:30 ET | Source: Moleculin Biotech, Inc.

Moleculin Biotech, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2018

HOUSTON, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug...
November 13, 2018 07:30 ET | Source: Serengeti Resources Inc

Kwanika Copper Corporation Drills 500 Metres of 0.66% Cu, 0.80g/t Au (2.19 g/t Au Eq) Including 113 Metres of 1.31% Cu, 1.31 g/t Au (4.09 g/t Au Eq) from near surface at Kwanika

VANCOUVER, British Columbia, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Serengeti Resources Inc. (SIR: TSX-V) ("Serengeti" or "the Company") is pleased to report the second batch of assay results from the...
November 13, 2018 07:30 ET | Source: Idaho Champion Gold Mines

Idaho Champion Intersects 0.88 Grams Per Tonne Gold Over 10.50 Metres in Highly Oxidized Zone at the Baner Project

TORONTO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Idaho Champion Gold Mines Canada Inc. (CSE: ITKO) (“Idaho Champion” or the "Company"), is pleased to report assay results on the final three holes of the...
November 13, 2018 07:30 ET | Source: Cardtronics USA, Inc.

Cardtronics and Convenience Store Owner Parkland Fuel Partner to Expand ATM Access

280 additional ATM locations to display the TD brand TORONTO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Parkland Fuel Corporation (“Parkland”), the owner and operator of FasGas, Pioneer and other retail...
November 13, 2018 07:30 ET | Source: Eyenovia, Inc.

Eyenovia Announces FDA Acceptance of MicroStat IND Application for Mydriasis

Company on track to initiate Phase III trials in late November NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of...
November 13, 2018 07:30 ET | Source: Dare Bioscience, Inc.

Daré Bioscience Provides Business Update and Announces Third Quarter Financial Results

SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today provided a business update and announced financial...

1 ...153981 153982 153983 ...326067